Cobimetinib

From WikiMD.org
Jump to navigation Jump to search

Cobimetinib (pronounced as koh-bi-ME-ti-nib) is a type of cancer medication that interferes with the growth and spread of cancer cells in the body. It is used in combination with another medication called vemurafenib to treat a certain type of melanoma (skin cancer) that has spread to other parts of the body or cannot be removed by surgery.

Etymology

The name "Cobimetinib" is derived from the chemical structure of the drug. The prefix "Cobi-" is an abbreviation of the chemical name, while "-metinib" is a common suffix for drugs that inhibit kinase enzymes.

Usage

Cobimetinib is used in combination with vemurafenib to treat melanoma that has spread or cannot be removed by surgery. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.

Side Effects

Common side effects of cobimetinib include diarrhea, rash, nausea, fever, and photosensitivity. Serious side effects can include liver problems, skin problems, eye problems, and heart problems.

Related Terms

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski